Catasys, Inc. (NASDAQ:CATS) has been given an average recommendation of “Buy” by the nine research firms that are presently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a hold rating and six have issued a buy rating on the company. The average 12 month price target among brokerages that have updated their coverage on the stock in the last year is $18.50.
CATS has been the subject of several research reports. ValuEngine upgraded Catasys from a “hold” rating to a “buy” rating in a research note on Friday, November 1st. Zacks Investment Research downgraded Catasys from a “buy” rating to a “hold” rating in a research note on Wednesday, November 6th. Finally, BidaskClub downgraded Catasys from a “buy” rating to a “hold” rating in a research note on Thursday, October 3rd.
Hedge funds and other institutional investors have recently modified their holdings of the business. Russell Investments Group Ltd. bought a new position in Catasys in the 3rd quarter worth about $111,000. FNY Investment Advisers LLC boosted its stake in Catasys by 56.3% in the 2nd quarter. FNY Investment Advisers LLC now owns 6,088 shares of the company’s stock worth $117,000 after purchasing an additional 2,193 shares during the period. WINTON GROUP Ltd bought a new position in Catasys in the 2nd quarter worth about $227,000. CIBC Private Wealth Group LLC boosted its stake in Catasys by 5.2% in the 3rd quarter. CIBC Private Wealth Group LLC now owns 16,100 shares of the company’s stock worth $254,000 after purchasing an additional 800 shares during the period. Finally, Wells Fargo & Company MN boosted its stake in Catasys by 257.7% in the 2nd quarter. Wells Fargo & Company MN now owns 13,773 shares of the company’s stock worth $264,000 after purchasing an additional 9,923 shares during the period. Institutional investors and hedge funds own 21.09% of the company’s stock.
Shares of Catasys stock traded down $0.32 during trading hours on Friday, hitting $14.27. 4,801 shares of the company’s stock traded hands, compared to its average volume of 95,605. Catasys has a 12-month low of $8.71 and a 12-month high of $20.83. The stock has a market capitalization of $250.44 million, a price-to-earnings ratio of -16.03 and a beta of 1.62. The company has a fifty day simple moving average of $14.67 and a 200-day simple moving average of $16.63.
Catasys (NASDAQ:CATS) last posted its quarterly earnings results on Wednesday, November 13th. The company reported ($0.52) earnings per share for the quarter, missing the consensus estimate of ($0.32) by ($0.20). The firm had revenue of $8.85 million during the quarter, compared to the consensus estimate of $9.10 million. Sell-side analysts anticipate that Catasys will post -1.08 earnings per share for the current fiscal year.
Catasys, Inc provides big data predictive analytics, artificial intelligence and telehealth, combined with human intervention services to health plans and other third party payors. It offers OnTrak solution to improve treatment outcomes and lower the utilization of medical and behavioral health plan services.
Receive News & Ratings for Catasys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Catasys and related companies with MarketBeat.com's FREE daily email newsletter.